With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling ...

The NHS explains that Alzheimer's disease is believed to be driven by an abnormal build-up of two proteins, amyloid and tau. These deposits often develop around our existing brain cells, forming ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

This ancient herbal supplement is known for its potential to enhance memory and mental clarity by improving blood circulation ...

The fungi within our bodies may have a much greater effect on our health than we've long given them credit for.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street.However, the company ...

Trump diagnosed with common vein condition; White House says tests show no signs of heart failure or serious illness.

Alan Baker of Spokane, Washington, began to have serious problems with memory, confusion and movement when he was about 72 years old. When his wife, Mary, began to observe his decline and ...

Village Caregiving reports that caregivers for dementia patients need support. Key strategies include compassionate ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...